SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Bioinformatics on the Brink (The Scientist)
News | 12. 20. 2004
Companies struggle to diversify after disappointing software sales sink the sector.
